CDK4 and breast carcinoma: Cyclin-dependent kinases 4 and 6 inhibitors (CDK4/6i) restore the cell cycle by selectively inhibiting cyclin-dependent kinases 4 and 6, and block cell proliferation in a variety of tumor cells, including those of breast cancer [6].